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Validation of a blood group genotyping 
method based on high-resolution melting 
curve analysis
T. Gong, Y. Hong, N. Wang, X. Fu, and C. Zhou
The detection of polymorphism is the basis of blood group 
genotyping and phenotype prediction. Genotyping may be useful 
to determine blood groups when serologic results are unclear. 
The development and application of different methods for blood 
group genotyping may be needed as a substitute for blood group 
typing. The purpose of this study is to establish an approach for 
blood group genotyping based on a melting curve analysis of real-
time polymerase chain reaction (PCR). Using DNA extracted from 
whole blood, we developed and validated a DNA typing method 
for detecting DO*01/DO*02, DI*01/DI*02, LU*01/LU*02, and 
GYPB*03/GYPB*04 alleles using a melting curve analysis. All 
assays were confirmed with a commercial reagent containing 
sequence-specific primers (PCR-SSP), and a cohort of the samples 
was confirmed with sequencing. Results for all blood groups were 
within the range of specificity and assay variability. Genotypes 
of 300 blood donors were fully consistent with PCR-SSP data. 
The obtained genotype distribution is in complete concordance 
with existing data for the Chinese population. There are several 
advantages for this approach of blood group genotyping: lower 
contamination rates with PCR products in the laboratory, ease 
of performance, automation potential, and rapid cycling time. 
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Currently, typing for blood group antigens is performed 
by hemagglutination. As the gold standard for blood group 
phenotyping, hemagglutination assays may be inaccurate 
in some cases, such as for multiply transfused patients and 
patients with autoantibodies.1 In addition, the necessary 
reagents are costly and often limited in availability. Molecular 
typing techniques are emerging as a supplement to standard 
serology.2 Genotyping is often focused on a specific single-
nucleotide polymorphism (SNP) of a blood group gene; as a 
result, the assay may not detect additional rare polymorphisms 
that may be responsible for the formation of a different antigen.3 
In addition, the method of polymerase chain reaction (PCR) 
amplification with sequence-specific primers (PCR-SSP) for 
blood group genotyping may lead to contamination from the 
laboratory during the process of opening the reaction tube 
for electrophoresis, especially when screening a large number 
of samples. The purpose of this study was to explore a new 
method of blood group genotyping as a substitute for blood 
group typing. We developed a DNA method for genotyping 
DO*01/DO*02, DI*01/DI*02, LU*01/LU*02, and GYPB*03/
GYPB*04 alleles using a melting curve analysis. Assay results 
were within the range of specificity and assay variability.
Materials and Methods
Samples and Primers
A total of 300 EDTA blood samples were obtained from 
volunteer blood donors at Chengdu Blood Center, Sichuan, 
China. Genomic DNA was extracted using the commercially 
available TIANamp Genomic DNA Kit (Tiangen Biotech, 
Beijing, China) from 500-μL blood samples and prepared for 
subsequent PCR amplification. The special primers for DO*01/
DO*02, DI*01/DI*02, LU*01/LU*02, and GYPB*03/GYPB*04 
were designed with Primer Premier 5.0 (Premier Biosoft, Palo 
Alto, CA). The forward primers for the alternative pairs of each 
blood group gene are the same, whereas the reverse primers 
are different by only one or two bases at the 3′ terminal 
because of the specific SNP of the blood group genes. Human 
β-actin primer served as the internal control for DO*01/
DO*02, DI*01/DI*02, and LU*01/LU*02, and human growth 
hormone (HGH) primer was the internal control for GYPB*03/
GYPB*04. Sequences of primers are shown in Table 1. 
Melting Curve Analysis
PCR was carried out in a 10-μL reaction volume consisting 
of 10 ng purified genomic DNA, 10 pmol of each of the primers, 
and 1 U Taq DNA polymerase (Takara, Dalian, China). PCR 
was performed with 1 cycle at 94°C for 2 minutes, followed by 
30 cycles of 94°C for 30 seconds, 62°C for 15 seconds, and 72°C 
for 15 seconds. After the amplification phase, a melting curve 
analysis for DO*01/DO*02, DI*01/DI*02, LU*01/LU*02, and 
GYPB*03/GYPB*04 was performed. Each allele was amplified 
separately; for example, DO*01 was interrogated in one tube, 
and DO*02 in another tube.
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Validation Process
The assays were validated in terms of specificity with 
another commercial reagent (Human MNS, Duffy, Kell, 
Dombrock, Diego, Kidd and Lutheran blood type genotyping 
kit, PCR-SSP, Tianjin Super Biotechnology Developing Co. 
Ltd., China). PCR assays were performed to ascertain the 
specificity with 1 cycle at 96°C for 2 minutes followed by 5 
cycles of 96°C for 20 seconds and 68°C for 60 seconds; 10 
cycles of 96°C for 20 seconds, 65°C for 45 seconds, and 72°C 
for 30 seconds; and 15 cycles of 96°C for 20 seconds, 62°C for 
45 seconds, 72°C for 30 seconds, and 72°C for 2 minutes. The 
final PCR products were separated by 2 percent agarose gels 
that were stained with ethidium bromide.
In addition, the validity of the melting curve analysis 
was also verified by sequencing. Five samples of Dombrock 
phenotype (DO) that included 2 DO*01/DO*02, 1 DO*01/
DO*01, and 2 DO*02/DO*02 defined by our laboratory-
developed method were sequenced using the BigDye 
Terminator v3.1 Cycle Sequencing Kit in an ABI 3730 analyzer 
(Applied Biosystems, Inc., Foster City, CA). 
Results
All assays performed best with a DNA input of 10 ng, 
which showed the highest and best-defined peaks. For all 
reactions, there was no measurable 
influence of different users or amplification 
instruments, underscoring the repro-
ducibility of this approach. In all cases, 
the genotypes were easily identified 
by the differences of melting curves. 
The genotype results for the Do(a–b+) 
phenotype are shown in Figure 1A 
[Do(a–)] and 1B [Do(b+)], and results for 
Di(a–b+) are shown in Figure 1C [Di(a–)] 
and 1D [Di(b+)], as well as Lu(a–b+) and 
Ss(S–s+) in Figure 2. To determine the 
specificity of the approach based on the 
melting curve analysis, we compared the 
DO*01/DO*02, DI*01/DI*02, LU*01/
LU*02, and GYPB*03/GYPB*04 blood 
groups with the determined genotype. 
It revealed a 100 percent genotype 
correlation with the different genotypes 
(Table 2). Genotypes of 300 blood donors 
were fully consistent with the data obtained 
by PCR-SSP. The sequencing results 
further supported the validity of this 
typing method (Fig. 3). The obtained genotype distribution 
is in complete concordance with existing data for the China 
population (Table 3).4,5
Discussion
There are many ways to genotype for blood groups. Some 
papers described a genotyping method by high-resolution 
melting curve analysis to predict red cell antigen expression.6–8 
Genotyping can also be performed by allele-specific 
fluorescence. Some closed-tube fluorescent methods for blood 
group genotyping do not require probes, but most methods are 
based on PCR and use fluorescent oligonucleotide probes. Chen 
et al.8 reported that the Ael and Bel blood types were rapidly 
detected by real-time PCR and melting curve analysis. In their 
methods, the real-time PCR was performed in the Lightcycler 
thermal cycler and the allele-specific melting behavior of 
fluorophore-labeled hybridization probe was used to detect 
Ael- and Bel-specific genotyping. However, labeled probes 
are costly when compared with real-time PCR with SYBR 
Green I. Homogeneous, closed-tube methods for blood group 
genotyping that do not require a separation step are attractive 
for their simplicity and containment of amplified products. 
Genotyping of SNPs by high-resolution melting curve analysis 
in products has been reported.9 We developed a blood group 
Table 1. Sequences of primers
Primer* Sequence Position† Size (bp)
Product 
Temperature (°C)
Di-F T G G G G T G G TA G A G G G T G C 21,746 to 21,763 161 88.2
Dia-R GGGCAGGGCCAGGGAGGCTA 21,901 to 21,882
Dib-R GGGCAGGGCCAGGGAGGCAG 21,901 to 21,882
Do-F GT T TGGGA ACCAGACACTAT T 7839 to 7859 155 82.3
Doa-R GACCTCA ACTGCA ACCAGCT 7994 to 7977
Dob-R GACCTCA ACTGCA ACCAGCC 7994 to 7977
Lu-F GGGACCAGGGAGACCCATA A 7954 to 7973 173 86.7
Lua-R CATC TCAG C C G AG G C TAGT T 8127 to 8110
Lub-R CATCTCAGC C G AGGCTAGTC 8127 to 8110
Ss-F C C C G C A G A A C A G T T T G A T 2070 to 2087 112 77.5
SS-R AC G ATGG ACA AGT TGTC C CA 2181 to 2162
ss-R ACGATGGACA AGT TGTCCCG 2181 to 2162
ß-actin-F G ATG AG AT TG G C ATG G C T T T 1207 to 1226 125 77.1
ß-actin-R C AC C T TC AC C GT TC C AGT T T 1331 to 1312
HGH-F G C C T TC C CA AC CAT TC C C T T 893 to 913 427 88.0
HGH-R TCACGGATTTCTGTTGTGTTTC 1319 to 1298
* F and R indicate forward and reverse primers, respectively.
† The last base of the downstream primers is the single-nucleotide polymorphism. Numbering of DO, 
DI, LU, and GYPB (Ss) is according to the sequenced BAC clone, GenBank acc. no.: NG_007477.1, 
BC099629.3, NG_007480.1, and HQ_402219, respectively; ß-actin and human growth hormone 
(HGH) reference sequences, GenBank acc. no.: XM-007447079 and M13438, respectively.
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genotyping method based on allelic discrimination by melting 
curve analysis that is suitable for the different requirements 
in an immunohematologic setting.10 As the costs for reagents 
remain the same, differences exist in consumables. The cost of 
this laboratory-developed high-resolution melting curve assay 
is approximately one-third the cost of the commercial SSP-
PCR genotyping kit in our laboratory. From an economical 
point of view, the melting curve analysis offers a platform for 
rare blood group molecular screening from a large number 
of samples. The detection of blood groups in a closed-tube 
reaction by unique melting behavior of the primer resulting 
from sequence variations saves on reagent costs.
Novaretti et al.6 described a real-time PCR and melting 
curve analysis method for Diego blood group genotyping. We 
also tried to perform the testing using one tube for both alleles 
of DO*01/DO*02, DI*01/DI*02, LU*01/LU*02, and GYPB*03/
GYPB*04, but we were unable to identify both alleles because 
the product’s size and melting temperature are high owing to 
the similarity of sequences between the two alleles.
Ansart-Pirenne et al.7 described FY*02.M real-time PCR 
with melting curve analysis associated with a complete one-
step real-time FY genotyping. Forty-seven samples were 
studied by real-time PCR, based on fluorescence resonance 
energy transfer (FRET) technology. Obviously, although the 
method of real-time PCR and FRET-PCR is useful for the 
correct typing of blood donors, it is less suitable for use in the 
screening of rare blood groups because of the technical skills 
and precision instruments required.
We were unable to validate the assay for the LU c.230A 
SNP. For future work, we will consider obtaining commercially 
Fig. 1. Melting curve analysis of DO*01/DO*02 and DI*01/DI*02. The genotype results of Do(a–b+) phenotype are shown in panels A and 
B. A: Do(a–), no reaction for DO*01, only the ß-actin peak identified. B: Do(b+), both the ß-actin and DO*02 peaks are visible. The genotype 
results of Di(a–b+) phenotype are shown in panels C and D. C: Di(a–), no reaction for DI*01, only the ß-actin peak identified. D: Di(b+), both 
the ß-actin and DI*02 peaks are visible.
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Fig. 2. Melting curve analysis of LU*01/LU*02 and GYPB*03/GYPB*04. The genotype results of the Lu(a–b+) phenotype are shown in 
panels A and B. A: Lu(a–), no reaction for LU*01, only the ß-actin peak identified. B: Lu(b+), both the ß-actin and LU*02 peaks are visible. 
The genotype results of GYPB*03/GYPB*04 (S–s+) are shown in panels C and D. C: S–, no reaction for GYPB*03, only the human growth 
hormone (HGH) peak identified. D: s+, both the HGH and GYPB*04 peaks are visible.
Fig. 3. Sequencing results (reverse) for the Dombrock blood group. The Dombrock genotype of donors A, B, and C, tested by the new 
method, is DO*01/DO*01, DO*01/DO*02, and DO*02/DO*02, respectively. The arrow indicates nucleotide position at 7975(NG_007477.1), 
and the genotypes of donors A, B, and C have the base C, C/T, and T at 7975 of the DO gene, respectively. Dombrock genotypes of these 
three donors were consistent with the data of sequencing.
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available DNA (such as from Coriell Cell Repositories) from 
individuals of other ethnic groups to include in genotyping 
assay validations. The laboratory-developed high-resolution 
melting curve method is a medium throughput assay.
The advantages of this real-time PCR method are its rapid 
PCR performance and the fact that the whole amplification and 
detection process is performed in a closed system, therefore 
minimizing the contamination risk. The software-operated 
calculation of melting points enhances the certainty of the 
results. Methods applied in screening for rare blood groups 
must show a high degree of robustness. The local genotype 
and allele distribution for all examined blood groups mirror 
the known occurrence in a Chinese population as described 
before.4,5 In summary, the combination of real-time PCR 
and melting curve analysis provides a useful tool for blood 
group determination. The genotyping process can be finished 
within 90 minutes after DNA purification. We suggest that 
this particular molecular methodology may be successfully 
adopted as a method for screening a large number of samples 
for rare blood groups, and we foresee the further extension of 
real-time PCR assays for routine genotyping.
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Do(a+b+) DO*01/DO*02 26 26
Do(a+b–) DO*01/DO*01 1 1
Do(a–b+) DO*02/DO*02 273 273
Di(a+b+) DI*01/DI*02 18 18
Di(a+b–) DI*01/DI*01 0 0
Di(a–b+) DI*02/DI*02 292 292
Lu(a+b+) LU*01/LU*02 0 0
Lu(a+b–) LU*01/LU*01 0 0
Lu(a–b+) LU*02/LU*02 300 300
Ss(S+s+) GYPB*03/GYPB*04 9 9
Ss(S+s–) GYPB*03/GYPB*03 1 1
Ss(S–s+) GYPB*04/GYPB*04 290 290
PCR = polymerase chain reaction; SSP = sequence-specific primer.
Table 3. DO*01/DO*02, DI*01/DI*02, LU*01/LU*02, and GYPB*03/GYPB*04 distribution among China and Chengdu populations
Area
Frequency (n)
DO*01 DO*02 DI*01 DI*02 LU*01 LU*02 GYPB*03 GYPB*04
China 0.1027 (292) 0.8973 (292) 0.0566 (299) 0.9990 (299) 0 (114) 1.0000 (114) 0.0225 (111) 0.9950 (111)
Chengdu† 0.0900 (300) 0.9100 (300) 0.0600 (300) 0.9400 (300) 0 (300) 1.0000 (300) 0.0333 (300) 0.9666 (300)
†These data were detected by the melting curve method.
